Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3924071
Max Phase: Preclinical
Molecular Formula: C20H16BrN5O2
Molecular Weight: 438.29
Molecule Type: Small molecule
Associated Items:
ID: ALA3924071
Max Phase: Preclinical
Molecular Formula: C20H16BrN5O2
Molecular Weight: 438.29
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CCCCn1c(NC(=O)c2ccc(Br)o2)c(C#N)c2nc3ccccc3nc21
Standard InChI: InChI=1S/C20H16BrN5O2/c1-2-3-10-26-18(25-20(27)15-8-9-16(21)28-15)12(11-22)17-19(26)24-14-7-5-4-6-13(14)23-17/h4-9H,2-3,10H2,1H3,(H,25,27)
Standard InChI Key: ZFJLOMZKRKMZEK-UHFFFAOYSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 438.29 | Molecular Weight (Monoisotopic): 437.0487 | AlogP: 4.86 | #Rotatable Bonds: 5 |
Polar Surface Area: 96.74 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 1 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.12 | CX Basic pKa: | CX LogP: 4.27 | CX LogD: 4.27 |
Aromatic Rings: 4 | Heavy Atoms: 28 | QED Weighted: 0.48 | Np Likeness Score: -1.90 |
1. (2015) Compounds and methods for treating tuberculosis infection, |
Source(1):